# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Lake Street analyst Ryan Meyers maintains PetMed Express (NASDAQ:PETS) with a Buy and lowers the price target from $9 to $7.
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target fro...
PetMed Express (NASDAQ:PETS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0....
Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology OfficerCompany Announ...